Ben Atkins | VP, Communications & IR |
Roger Crystal | President, Chief Executive Officer |
David O'Toole | Chief Financial Officer |
Brandon Folkes | Cantor Fitzgerald & Co. |
Carl Byrnes | Northland Securities |
David Bautz | Zacks Investment Research |
Greetings and welcome to the Opiant Pharmaceuticals' Third Quarter 2020 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question and answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Ben Atkins, VP of Investor Relations Communications of Opiant Pharmaceuticals.